Gregory Renza
Stock Analyst at Truist Financial
(4.73)
# 673
Out of 4,408 analysts
779
Total ratings
47.2%
Success rate
15.1%
Average return
Main Sectors:
Stocks Rated by Gregory Renza
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | n/a | $230.59 | - | 38 | Jun 15, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Buy | $36 | $31.82 | +13.14% | 41 | Jun 15, 2026 | |
| GMAB Genmab | Maintained: Buy | n/a | $24.58 | - | 2 | Jun 12, 2026 | |
| NUVB Nuvation Bio | Maintained: Buy | n/a | $5.14 | - | 25 | Jun 10, 2026 | |
| NUVL Nuvalent | Downgraded: Hold | $124 | $123.35 | +0.53% | 8 | Jun 10, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | n/a | $124.30 | - | 13 | Jun 9, 2026 | |
| ZYME Zymeworks | Initiated Coverage: Buy | $28 | $23.26 | +20.38% | 1 | Jun 9, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $32 | $17.04 | +87.79% | 26 | Jun 9, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | n/a | $268.20 | - | 14 | Jun 2, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | n/a | $30.23 | - | 31 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $4 | $3.51 | +13.96% | 16 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $135 | $98.26 | +37.39% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.00 | - | 35 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $160.06 | - | 2 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $83 | $29.63 | +180.12% | 1 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.57 | - | 19 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $778 | $614.98 | +26.51% | 11 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.94 | - | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $12.21 | +137.51% | 31 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $16.30 | +114.72% | 33 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $18.55 | +104.85% | 1 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $325 → $327 | $350.53 | -6.71% | 37 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $4.15 | +68.67% | 8 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $22 | $17.34 | +28.84% | 3 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $21.27 | n/a | 57 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.05 | n/a | 24 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $53.00 | n/a | 31 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $1.10 | n/a | 36 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $4.00 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $5.81 | n/a | 23 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $46 | $0.4805 | n/a | 8 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26 | $22.74 | n/a | 31 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $0.4433 | n/a | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $13 | $8.59 | n/a | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $49.91 | n/a | 26 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32.19 → $25.19 | $2.13 | n/a | 24 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2,160 → $180 | $14.60 | n/a | 11 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $80 | $0.6986 | n/a | 18 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 → $15 | $0.04 | n/a | 14 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $348 | $198.64 | n/a | 1 | Sep 8, 2015 |
Jazz Pharmaceuticals
Jun 15, 2026
Maintained: Buy
Price Target: n/a
Current: $230.59
Upside: -
Agios Pharmaceuticals
Jun 15, 2026
Maintained: Buy
Price Target: $36
Current: $31.82
Upside: +13.14%
Genmab
Jun 12, 2026
Maintained: Buy
Price Target: n/a
Current: $24.58
Upside: -
Nuvation Bio
Jun 10, 2026
Maintained: Buy
Price Target: n/a
Current: $5.14
Upside: -
Nuvalent
Jun 10, 2026
Downgraded: Hold
Price Target: $124
Current: $123.35
Upside: +0.53%
Gilead Sciences
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $124.30
Upside: -
Zymeworks
Jun 9, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $23.26
Upside: +20.38%
Nurix Therapeutics
Jun 9, 2026
Reiterated: Buy
Price Target: $32
Current: $17.04
Upside: +87.79%
BeOne Medicines AG
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $268.20
Upside: -
IDEAYA Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.23
Upside: -
Jun 2, 2026
Downgraded: Hold
Price Target: $17 → $4
Current: $3.51
Upside: +13.96%
Jun 2, 2026
Maintained: Buy
Price Target: $140 → $135
Current: $98.26
Upside: +37.39%
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $4.00
Upside: -
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $160.06
Upside: -
May 27, 2026
Initiated Coverage: Buy
Price Target: $83
Current: $29.63
Upside: +180.12%
May 27, 2026
Maintained: Buy
Price Target: n/a
Current: $59.57
Upside: -
May 18, 2026
Maintained: Buy
Price Target: $778
Current: $614.98
Upside: +26.51%
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $2.94
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $29
Current: $12.21
Upside: +137.51%
May 6, 2026
Maintained: Buy
Price Target: $33 → $35
Current: $16.30
Upside: +114.72%
May 4, 2026
Reiterated: Buy
Price Target: $38
Current: $18.55
Upside: +104.85%
May 1, 2026
Maintained: Hold
Price Target: $325 → $327
Current: $350.53
Upside: -6.71%
May 1, 2026
Maintained: Hold
Price Target: $8 → $7
Current: $4.15
Upside: +68.67%
Apr 24, 2026
Maintained: Buy
Price Target: $51 → $22
Current: $17.34
Upside: +28.84%
May 19, 2025
Reiterated: Buy
Price Target: $26
Current: $21.27
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: $8
Current: $1.05
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $40
Current: $53.00
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $5
Current: $1.10
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $16
Current: $4.00
Upside: n/a
May 13, 2025
Maintained: Hold
Price Target: $20
Current: $5.81
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: $48 → $46
Current: $0.4805
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $26
Current: $22.74
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $16
Current: $0.4433
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $12 → $13
Current: $8.59
Upside: n/a
May 6, 2025
Maintained: Hold
Price Target: $38
Current: $49.91
Upside: n/a
Nov 10, 2023
Maintained: Buy
Price Target: $32.19 → $25.19
Current: $2.13
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: $2,160 → $180
Current: $14.60
Upside: n/a
Mar 16, 2022
Maintained: Hold
Price Target: $5 → $80
Current: $0.6986
Upside: n/a
Nov 12, 2021
Maintained: Hold
Price Target: $1 → $15
Current: $0.04
Upside: n/a
Sep 8, 2015
Rated: Buy
Price Target: $348
Current: $198.64
Upside: n/a